The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment ...

In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years.

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

The company is developing psychedelics for depression, and hopes to go public within a year of its next published results, per documents seen by BI.

This new treatment could help bring relief for millions of Americans struggling with depression. The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for ...

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression. The drug, SPRAVATO, is made by Johnson & Johnson and was first approved in 2019 for adults ...

Narcan nasal spray is a pure opioid antagonist indicated for emergency use to reverse known or suspected opioid overdose, as manifested by respiratory and/or severe central nervous system depression.

A nasal spray, referred to as nasal anti-CD3 ... “It goes beyond their discharge, with all the spectrum of PTSD, anxiety, depression, and cognitive decline.” Following successful trials ...

Mental health providers in Central Illinois offering ketamine say it has changed patients' lives for the better. Still, only ...